Viridian Therapeutics • VRDN
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Stephen Mahoney$916.4M
Market Cap • 19/04/20242014
(há 10 anos)
2014
(10 years ago)
NASDAQ
Listagem
Waltham
Sede • Massachusetts86
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
VRDNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.